Drug-induced phospholipidosis

被引:267
作者
Anderson, Nora
Borlak, Juergen
机构
[1] Fraunhofer Inst Toxicol & Expt Med, D-30625 Hannover, Germany
[2] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-30625 Hannover, Germany
关键词
drug-induced phospholipidosis; lysosome; cationic amphiphilic drug; lamellar body;
D O I
10.1016/j.febslet.2006.08.061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drug-induced phospholipidosis is characterized by intracellular accumulation of phospholipids with lamellar bodies, most likely from an impaired phospholipid metabolism of the lysosome. brgans affected by phospholipidosis exhibit inflammatory reactions and histopathological changes. Despite significant advances in the understanding of drug-altered lipid metabolism, the relationship between impaired phospholipid metabolism and drug-induced toxicity remains enigmatic. Here we review molecular features of inheritable lysosomal storage disorders as a molecular mimicry of drug-induced phospholipidosis for an improved understanding of adverse drug reaction. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:5533 / 5540
页数:8
相关论文
共 72 条
[51]  
Reasor MJ, 1996, P SOC EXP BIOL MED, V211, P346
[52]   LYSOSOMAL STABILIZING EFFECT OF CHLORPHENTERMINE IN THE RABBIT ALVEOLAR MACROPHAGE [J].
REASOR, MJ ;
WALKER, ER .
GENERAL PHARMACOLOGY, 1979, 10 (02) :83-88
[53]  
REASOR MJ, 1984, FED PROC, V43, P2578
[54]   Drug-induced phospholipidosis: Are there functional consequences? [J].
Reasor, MJ ;
Kacew, S .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 226 (09) :825-830
[56]  
ROBISON R L, 1985, Toxicologic Pathology, V13, P335
[57]   Gaucher disease with nephrotic syndrome: Response to enzyme replacement therapy [J].
Santoro, D ;
Rosenbloom, BE ;
Cohen, AH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (01)
[58]  
Sarma, 1997, J Cardiovasc Pharmacol Ther, V2, P53, DOI 10.1177/107424849700200107
[59]   CHLORPHENTERMINE SUPPRESSES THE PHOSPHATIDYLINOSITOL PATHWAY IN CONCANAVALIN A-ACTIVATED MOUSE SPLENIC LYMPHOCYTES [J].
SAUERS, LJ ;
WIERDA, D ;
REASOR, MJ .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1988, 10 (01) :1-19
[60]   A toxicogenomic approach to drug-induced phospholipidosis:: Analysis of its induction mechanism and establishment of a novel in vitro screening system [J].
Sawada, H ;
Takami, K ;
Asahi, S .
TOXICOLOGICAL SCIENCES, 2005, 83 (02) :282-292